Contact Us
Drug Search Results
More Filters [+]

Thyrotropin alfa

Alternative Names: thyrotropin alfa, thyrogen
Latest Update: 2025-01-10
Latest Update Note: Clinical Trial Update

Product Description

Thyrotropin alfa injection is a form of human thyroid stimulating hormone (TSH). It is used with or without radioactive iodine imaging to test the presence of thyroglobulin (Tg) in patients with thyroid cancer. (Sourced from: https://www.mayoclinic.org/drugs-supplements/thyrotropin-alfa-intramuscular-route/description/drg-20066371)

Mechanisms of Action: THR Agonist

Novel Mechanism: No

Modality: Diagnostic Agent

Route of Administration: Intramuscular,Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Austria | Belgium | Brazil | Chile | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Estonia | European Medicines Agency | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | Indonesia | Ireland | Italy | Japan | Jordan | Latvia | Lebanon | Malaysia | Netherlands | Norway | Peru | Philippines | Poland | Portugal | Romania | Saudi Arabia | Serbia | Singapore | Slovakia | South Africa | Spain | Sweden | Switzerland | Taiwan | Thailand | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: Oncology Solid Tumor Unspecified | Thyroid Cancer | Oncology Unspecified

Known Adverse Events: Stroke | Headache | Pain Unspecified | Hyperthyroidism | Central Nervous System Cancer | Oncology Solid Tumor Unspecified | Thyroid Cancer | Urologic Cancer | Oncology Unspecified | Pregnancy Outcomes

Company: Sanofi
Company Location: PARIS I0 75008
Company CEO: Paul Hudson
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Thyrotropin alfa

Countries in Clinic: New Zealand

Active Clinical Trial Count: 1

Highest Development Phases

Phase 1: Autoimmune Disease Unspecified|Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
2006-7041-83/hah

P1

Not yet recruiting

Healthy Volunteers|Autoimmune Disease Unspecified

2018-01-30

Recent News Events

Date

Type

Title

02/28/2023

News Article

 Thyroid Cancer Diagnostics Market Size to Reach USD 11,063.67 Million Globally by 2030, Size, Share, Demand, Trends and Growth Opportunities

12/08/2020

News Article

 Candel Therapeutics Appoints Pharma Veteran and Immunologist Paul-Peter Tak, M.D., Ph.D., as Chief Executive Officer; Expands Leadership Team With Chief Financial Officer, Chief Business Officer and Chief Regulatory Officer Appointments

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions